AIIMS building in Haryana's Jhajjar will be used exclusively to treat COVID-19 patients, the Indian Council of Medical Research (ICMR) Director-General said on March 22.
For our comprehensive coverage and latest updates on COVID-19 click here.
"AIIMS building in Haryana's Jhajjar, which has 800 beds, will be used exclusively to treat COVID-19 patients," said Bhargava while addressing a press conference. "60 private labs have registered so far to conduct tests. Many of them are being approved as we speak," he said.